Skip to main content
Screener/Healthcare/Biotechnology

ABUS Arbutus Biopharma Corporation

NASDAQ
$4.45-0.07 (-1.66%)
$3.04
$5.07
$4.39
$4.58
EPS (TTM)$0.82
P/E Ratio5.45
Dividend Yield
Market Cap$898.8M
Volume2.61M
Prev Close$4.52
Revenue & Operating Income
Revenue
Operating Income
Net Income
Positive
Negative
Free Cash Flow
Positive
Negative
Gross Profit & Operating Expenses
Gross Profit
Operating Expenses
Earnings Per Share
Positive
Negative
Balance Sheet
Total Assets
Total Liabilities
Cash & Equivalents
Cash & Equivalents
Shares Outstanding
Shares Outstanding
Margins
Gross Margin
Operating Margin
Net Margin

Quarterly Results

QuarterRevenueNet IncomeEPSGross MarginNet Margin
Q1 '26$179.1M$169.7M$0.87100.0%94.7%
Q4 '25$1.1M-$3.8M$-0.0299.0%-357.4%
Q3 '25$529K-$7.7M$-0.0497.9%-1463.5%
Q2 '25$10.7M$2.5M$0.01100.0%23.5%
Q1 '25$1.8M-$24.5M$-0.13-407.9%-1390.4%
Q4 '24$1.6M-$12.5M$-0.07-459.7%-796.2%
Q3 '24$1.3M-$19.7M$-0.10100.0%-1472.5%
Q2 '24$1.7M-$19.8M$-0.11100.0%-1146.9%
Get Your Daily Market Recap